Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Change in Cash (2016 - 2025)

Historic Change in Cash for Avalon GloboCare (ALBT) over the last 10 years, with Q3 2025 value amounting to $132399.0.

  • Avalon GloboCare's Change in Cash fell 8392.48% to $132399.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$690266.0, marking a year-over-year decrease of 20114.88%. This contributed to the annual value of $2.6 million for FY2024, which is 25074.14% up from last year.
  • According to the latest figures from Q3 2025, Avalon GloboCare's Change in Cash is $132399.0, which was down 8392.48% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Avalon GloboCare's Change in Cash ranged from a high of $2.8 million in Q3 2022 and a low of -$1.9 million during Q4 2022
  • For the 5-year period, Avalon GloboCare's Change in Cash averaged around -$20665.6, with its median value being -$104896.0 (2024).
  • In the last 5 years, Avalon GloboCare's Change in Cash skyrocketed by 335009.67% in 2024 and then plummeted by 750842.64% in 2025.
  • Avalon GloboCare's Change in Cash (Quarter) stood at $275287.0 in 2021, then plummeted by 807.28% to -$1.9 million in 2022, then surged by 97.1% to -$56371.0 in 2023, then skyrocketed by 3350.1% to $1.8 million in 2024, then plummeted by 92.77% to $132399.0 in 2025.
  • Its last three reported values are $132399.0 in Q3 2025, -$1.2 million for Q2 2025, and -$1.5 million during Q1 2025.